Allogeneic bone marrow cocultured with human islets significantly improves islet survival and function in vivo

Transplantation

Volumn 95, Issue 6, 2013, Pages 801-809

  Luo, John Z Q ^a,b   Xiong, Fang ^a   Al Homsi, A Samer ^a   Ricordi, Camillo ^c   Luo, Luguang ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Allogeneic bone marrow; Diabetes; Human islets

Indexed keywords

GLUCOSE; HUMAN INSULIN; FLUORESCENT DYE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL MIGRATION; CELL PROLIFERATION; CELL SIZE; CELL SURVIVAL; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; ENDOTHELIAL PROGENITOR CELL; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; IMMUNE DEFICIENCY; IN VITRO STUDY; INSULIN BLOOD LEVEL; KIDNEY CAPSULE; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SURVIVAL TIME; ALLOTRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CYTOLOGY; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL DIABETES MELLITUS; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; METHODOLOGY; MOUSE MUTANT; PANCREAS ISLET; TIME;

ANIMALS; BLOOD GLUCOSE; BONE MARROW CELLS; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT DYES; HUMANS; HYPERGLYCEMIA; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, INBRED BALB C; MICE, SCID; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

MLCS; MLOWN;

EID: 84877602612     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31828235c7     Document Type: Article

References (48)

1. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355: 1318.
2. Rother KI, Harlan DM. Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. J Clin Invest 2004; 114: 877.
3. Azzi J, Geara AS, El-Sayegh S, et al. Immunological aspects of pancreatic islet cell transplantation. Expert Rev Clin Immunol 2010; 6: 111.
4. Cravedi P, van der Meer IM, Cattaneo S, et al. Successes and disappointments with clinical islet transplantation. Adv Exp Med Biol 2010; 654: 749.
5. Vaithilingam V, Tuch BE. Islet transplantation and encapsulation: an update on recent developments. Rev Diabet Stud 2011; 8: 51.
6. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
7. Davalli AM, Scaglia L, Zangen DH, et al. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 1996; 45: 1161.
8. Nagata M, Mullen Y, Matsuo S, et al. Destruction of islet isografts by severe nonspecific inflammation. Transplant Proc 1990; 22: 855.
9. Chahine AA, Stoeckert C, Lau HT. Local immunomodulation to promote co-stimulatory blockade. Clin Transplant 1995; 9: 215.
10. + T lymphocytes in primary nonfunction and classic rejection of islet allografts. J Exp Med 1990; 172: 291.
11. Barshes NR, Wyllie S, Goss JA. Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol 2005; 77: 587.
12. Johansson U, Rasmusson I, Niclou SP, et al. Formation of composite endothelial cell-mesenchymal stem cell islets: a novel approach to promote islet revascularization. Diabetes 2008; 57: 2393.
13. Noguchi H, Naziruddin B, Onaca N, et al. Comparison of modified Celsior solution and M-Kyoto solution for pancreas preservation in human islet isolation. Cell Transplant 2010; 19: 751.
14. Miyamoto M, Morimoto Y, Balamurugan AN, et al Improvement of modified two-layer preservation method (PFC/Kyoto solution) in islet isolation from breeder pigs. Transplant Proc 2000; 32: 1660.
15. Sandler S, Andersson A, Korsgren O, et al. Tissue culture of human fetal pancreas. Effects of nicotinamide on insulin production and formation of islet like cell clusters. Diabetes 1989; 38: 168.
16. Eizirik DL, Sandler S, Welsh N, et al. Nicotinamide decreases nitric oxide production and partially protects human pancreatic islets against the suppressive effects of combinations of cytokines. Autoim-munity 1994; 19: 193.
17. Wang H, Ferran C, Attanasio C, et al. Induction of protective genes leads to islet survival and function. J Transplant 2011; 2011: 141898.
18. Giannoukakis N, Rudert WA, Ghivizzani SC, et al. Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro. Diabetes 1999; 48: 1730.
19. Embury J, Klein D, Pileggi A, et al. Proteins linked to a protein transduction domain efficiently transduce pancreatic islets. Diabetes 2001; 50: 1706.
20. Luo L, Badiavas E, Luo JZ, et al. Allogeneic bone marrow supports human islet beta cell survival and function over six months. Biochem Biophys Res Commun 2007; 361: 859.
21. Maedler K, Sergeev P, Ris F, et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 2002; 110: 851.
22. Welsh N, Cnop M, Kharroubi I, et al. Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets? Diabetes 2005; 54: 3238.
23. Lu Y, Jin X, Chen Y, et al. Mesenchymal stem cells protect islets from hypoxia/reoxygenation-induced injury. Cell Biochem Funct 2010; 28: 637.
24. Park KS, Kim YS, Kim JH, et al. Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and an-giogenesis of isolated islets after transplantation. Transplantation 2010; 89: 509.
25. Karaoz E, Genc ZS, Demircan PC, et al. Protection of rat pancreatic islet function and viability by coculture with rat bone marrow-derived mesenchymal stem cells. Cell Death Dis 2010; 1: e36.
26. Brissova M, Powers AC. Revascularization of transplanted islets: can it be improved? Diabetes 2008; 57: 2269.
27. Noguchi H, Naziruddin B, Shimoda M, et al. Comparison of fresh and cultured islets from human and porcine pancreata. Transplant Proc 2010; 42: 2084.
28. Schroppel B, Zhang N, Chen P, et al. Role of donor-derived monocyte chemoattractant protein-1 in murine islet transplantation. J Am Soc Nephrol 2005; 16: 444.
29. Amrani A, Verdaguer J, Thiessen S, et al. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes. J Clin Invest 2000; 105: 459.
30. Luo JZ, Xiong F, Al-Homsi AS, et al. Human BM stem cells initiate angiogenesis in human islets in vitro. Bone Marrow Transplant 2011; 46: 1128.
31. Sakata N, Chan NK, Chrisler J, et al. Bone marrow cell cotrans-plantation with islets improves their vascularization and function. Transplantation 2010; 89: 686.
32. Ito T, Itakura S, Todorov I, et al. Mesenchymal stem cell and islet co-transplantation promotes graft revascularization and function. Transplantation 2010; 89: 1438.
33. Figliuzzi M, Cornolti R, Perico N, et al. Bone marrow-derived mes-enchymal stem cells improve islet graft function in diabetic rats. Transplant Proc 2009; 41: 1797.
34. Wu XH, Liu CP, Xu KF, et al. Reversal of hyperglycemia in diabetic rats by portal vein transplantation of islet-like cells generated from bone marrow mesenchymal stem cells. World J Gastroenterol 2007; 13: 3342.
35. Oh SH, Muzzonigro TM, Bae SH, et al. Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Lab Invest 2004; 84: 607.
36. Ding Y, Xu D, Feng G, et al. Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and-9. Diabetes 2009; 58: 1797.
37. Traktuev DO, Merfeld-Clauss S, Li J, et al. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res 2008; 102: 77.
38. Zorina TD, Subbotin VM, Bertera S, et al. Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes. Stem Cells 2003; 21: 377.
39. Ianus A, Holz GG, Theise ND, et al. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 2003; 111: 843.
40. Hess D, Li L, Martin M, et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 2003; 21: 763.
41. Sordi V, Malosio ML, Marchesi F, et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005; 106: 419.
42. Exner BG, Fowler K, Ildstad ST. Tolerance induction for islet transplantation. Ann Transplant 1997; 2: 77.
43. Sajic M, Hunt DP, Lee W, et al. Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation. PLoS One 2012; 7: e30708.
44. Neshati Z, Matin MM, Bahrami AR, et al. Differentiation of mesen-chymal stem cells to insulin-producing cells and their impact on type 1 diabetic rats. J Physiol Biochem 2010; 66: 181.
45. Iskovich S, Goldenberg-Cohen N, Stein J, et al. Beta-cell neogenesis: experimental considerations in adult stem cell differentiation. Stem Cells Dev 2011; 20: 569.
46. Choi JB, Uchino H, Azuma K, et al. Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells. Diabetologia 2003; 46: 1366.
47. Lechner A, Yang YG, Blacken RA, et al. No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. Diabetes 2004; 53: 616.
48. + cells migration into pancreatic islet and conversion into insulin-positive cells in vivo. PLoS One 2009; 4: e4504.